Fluvastatin
Authors:
- 1 November 2002
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Pharmacotherapy
- Vol. 3 (11) , 1631-1641
Abstract
Fluvastatin was the first wholly synthetic statin to the market and is effective in reducing total and low density lipoprotein cholesterol, which translates into reductions in coronary heart disease events. The Lescol Intervention Prevention Study has established the effectiveness of the early use of statins in reducing recurrent events in high-risk patients with coronary heart disease post percutaneous coronary interventions. Fluvastatin is well-tolerated with few side effects. The occurrence of significant abnormalities in liver enzymes is infrequent, and the risk of myositis and rhabdomyolysis seems to be less than with other statins. There have been no reports of fatal rhabdomyolysis to date. The potential for drug interactions with fluvastatin is low. It seems safe in combination with cyclosporin and there have been few reports of rhabdomyolysis when using fluvastatin in combination with other lipid-lowering agents. It is nevertheless important to be vigilant for this potentially important side effec...Keywords
This publication has 29 references indexed in Scilit:
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 2002
- Pharmacokinetics of Fluvastatin in Subjects with Renal Impairment and Nephrotic SyndromeThe Journal of Clinical Pharmacology, 2002
- Cerivastatin and Reports of Fatal RhabdomyolysisNew England Journal of Medicine, 2002
- Pharmacokinetics and Pharmacodynamics of Fluvastatin in Heart Transplant Recipients Taking Cyclosporine AJournal of Cardiovascular Pharmacology and Therapeutics, 2001
- Effect of statin therapy on restenosis after coronary stent implantationThe American Journal of Cardiology, 2000
- Effect of combined fluvastatin-fenofibrate therapy compared with fenofibrate monotherapy in severe primary hypercholesterolemiaThe American Journal of Cardiology, 2000
- Fluvastatin in combination with cyclosporin in renal transplant recipients: a review of clinical and safety experience. REVIEW ARTICLEJournal of Clinical Pharmacy and Therapeutics, 1999
- The effect of fluvastatin on cardiac events in patients with symptomatic coronary artery disease during one year of treatmentAtherosclerosis, 1999
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Elderly patients with hypercholesterolaemiaCoronary Artery Disease, 1998